[HTML][HTML] Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease

F Åberg, CD Byrne, CJ Pirola, V Männistö… - Journal of …, 2023 - Elsevier
Alcohol use and metabolic syndrome are highly prevalent in the population and frequently
co-exist. Both are implicated in a large range of health problems, including chronic liver …

Longitudinal outcomes associated with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of 129 studies

KE Chan, EYH Ong, CH Chung, CEY Ong… - Clinical …, 2024 - Elsevier
Background & Aims The progression of metabolic dysfunction-associated steatotic liver
disease (MASLD) has been found to manifest in a series of hepatic and extrahepatic …

Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease

S Lim, JW Kim, G Targher - Trends in Endocrinology & Metabolism, 2021 - cell.com
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic condition
characterized by hepatic fat accumulation combined with underlying metabolic …

Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?

A Lonardo, F Nascimbeni, A Mantovani, G Targher - Journal of hepatology, 2018 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) has become one of the most common forms of
chronic liver disease worldwide and its prevalence is expected to continue rising. NAFLD …

Nonalcoholic fatty liver disease: an emerging driver of hypertension

YC Zhao, GJ Zhao, Z Chen, ZG She, J Cai, H Li - Hypertension, 2020 - ahajournals.org
Hypertension, a multifactorial disorder resulting from the interplay between genetic
predisposition and environmental risk factors, affects≈ 30% of adults. Emerging evidence …

[HTML][HTML] Bayesian networks in healthcare: Distribution by medical condition

S McLachlan, K Dube, GA Hitman, NE Fenton… - Artificial intelligence in …, 2020 - Elsevier
Bayesian networks (BNs) have received increasing research attention that is not matched by
adoption in practice and yet have potential to significantly benefit healthcare. Hitherto …

[HTML][HTML] History of nonalcoholic fatty liver disease

A Lonardo, S Leoni, KA Alswat, Y Fouad - International Journal of …, 2020 - mdpi.com
Based on the assumption that characterizing the history of a disease will help in improving
practice while offering a clue to research, this article aims at reviewing the history of …

Nonalcoholic fatty liver disease: Evolving paradigms

A Lonardo, F Nascimbeni… - World journal of …, 2017 - pmc.ncbi.nlm.nih.gov
In the last years new evidence has accumulated on nonalcoholic fatty liver disease (NAFLD)
challenging the paradigms that had been holding the scene over the previous 30 years …

Progress and challenges in the prevention and control of nonalcoholic fatty liver disease

J Cai, XJ Zhang, H Li - Medicinal research reviews, 2019 - Wiley Online Library
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease
worldwide. Individuals with NAFLD have a high frequency of develo** progressive liver …

A comprehensive sco** review of Bayesian networks in healthcare: Past, present and future

E Kyrimi, S McLachlan, K Dube, MR Neves… - Artificial Intelligence in …, 2021 - Elsevier
No comprehensive review of Bayesian networks (BNs) in healthcare has been published in
the past, making it difficult to organize the research contributions in the present and identify …